Clinical Trial Update: Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for IBC0966 in patients with advanced malignant tumors across Phase 1 and Phase 2 is listed, but no results or status are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Tumors

Drugs mentioned

• IBC0966

Snippet

Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. | Conditions: Advanced Malignant Tumors | Phase 1, Phase 2 | Status: UNKNOWN